Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole + clotrimazole for treatment and prophylaxis of recurrent vulvovaginal candidiasis
2011-004718-40Phase 3Active
- Sponsor
- AISAR
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of metronidazole and clotrimazole in vulvovaginal candidiasis (VVC) and recurrent vulvovaginal candidiasis (RVVC), sponsored by AISAR. Primary endpoint: Reduction of recurrent vulvovaginal candidiasis events. Started Mar 2012; status: active.
02
Drugs
metronidazoleclotrimazole
03
Conditions
vulvovaginal candidiasis (VVC)recurrent vulvovaginal candidiasis (RVVC)
Beyond the preview
Go deeper on 2011-004718-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004718-40.